Coronavirus: Commission concludes exploratory talks with Valneva to secure a new potential vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.

Today’s finalisation of exploratory talks with Valneva come in addition to an already secured broad portfolio of vaccines to be produced in Europe, including the contracts already signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, and Moderna and exploratory talks concluded with Novavax. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective, as is already the case for BioNTech/Pfizer and Moderna, recently authorised in the EU. Member States are able to donate vaccines to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said: “The continuing COVID-19 pandemic in Europe and around the globe makes it more important than ever that all Member States have access to the broadest possible portfolio of vaccines to help protect people in Europe and beyond. Today’s step toward reaching an agreement with Valneva further complements the EU’s vaccines portfolio and demonstrates the Commission’s commitment to find a lasting solution to the pandemic.”

Stella Kyriakides, Commissioner for Health and Food Safety, said: “With this eighth vaccine, we are adding to our already broad and diversified range of vaccines in our portfolio. By doing this, we can maximise our chances of making sure that all citizens can have access to safe and effective of vaccinations by the end of 2021. All Member States have now started their vaccination campaigns and will start receiving an increasing number of doses in order to cover all their needs during this year.”

Valneva is a European biotechnology company developing an inactivated virus vaccine. This is a traditional vaccine technology, used for 60-70 years, with established methods and a high level of safety. Most of the influenza vaccines and many childhood vaccines use this technology. This is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.

The Commission, with the support of EU Member States, has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply all EU Member States.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies and has adopted further actions  to reinforce preparedness and response measures across the EU and a strategy on staying safe from COVID-19 during winter offering further support to Member States in the deployment of vaccines.

The Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees an additional €100 million in grant funding to support COVAX Facility and its objectives in the context of the Coronavirus Global Response. This €500 million from the EU budget combined with contributions from EU Member States and the EIB will be a key contribution for the COVAX Facility to ensure over one billion vaccine doses will be made available to people in low- and middle-income countries by the end of 2021.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Find unity ‘to halt Libya’s senseless unraveling’, UN envoy urges Security Council

Drones, disinfectant, distancing – Europe’s beaches open up

Syria: Guterres concerned over reported attacks in Idlib, calls for ‘full investigation’

The needs, challenges and power dynamics of refugee resettlement

Global Europe: MEPs back EU external cooperation funding instrument worth €79.5 billion

A more credible, dynamic, predictable and political EU accession process – Commission lays out its proposals

Commission disburses €14 billion under SURE to nine Member States

Belgium: keep up reforms to increase employment and productivity growth

The importance of including palliative care in the Universal Health Coverage and how to achieve it

How governments and mobile operators are easing network congestion during the COVID-19 crisis

UN condemns deadly attack against G5 Sahel force headquarters in Mali

Comprehensive listening: a tool to humanize Primary Healthcare and medical specialties

Landmine casualties high for third consecutive year despite record funding, latest monitor reports

Banks launch green charter to help shipping reduce its carbon footprint

Security Council must ‘come together’ to address the plight of children trapped in armed conflict, says UN envoy

3 ways AI will change the nature of cyber attacks

Human Rights: breaches in Cambodia, Uganda and Myanmar

Kazakhstan continues to push for a nuclear-free world

Monday’s Daily Brief: the cost of maternal healthcare, Sudan and Chad updates, sustainability in focus

These patients are sharing their data to improve healthcare standards

3 ways to accelerate the energy transition

A call for a new crop of innovators

Brexit: European Commission recommends the European Council (Article 50) to endorse the agreement reached on the revised Protocol on Ireland / Northern Ireland and revised Political Declaration

Brussels to tear down the trade wall with Mexico as opposed to Trump’s “walls”

European Court of Justice to Google: It is #righttobeforgotten but not #righttoberemembered

Netherlands: Budget MEPs back €1.2m in job-search aid for 450 redundant workers

The race to net-zero is on. This is how we can cross the finish line

Why the colour of your fruit and vegetables matters

Team Europe contributes €500 million to COVAX initiative to provide one billion COVID-19 vaccine doses for low and middle income countries

5G will drive Industry 4.0 in the Middle East and Africa

Antitrust: Commission fines car manufacturers €875 million for restricting competition in emission cleaning for new diesel passenger cars

What is hydroponics – and is it the future of farming?

UN health emergency committee to re-convene on global threat posed by China coronavirus

How can we measure real progress on the Sustainable Development Goals?

How can entrepreneurship tackle the migration crisis in the EU?

Powering through the pandemic

To build cities fit for the future, we need to think differently

US pardons for accused war criminals, contrary to international law: UN rights office

Judges urge Security Council to serve interests of all UN Member States

With a premature death every five seconds, air pollution is violation of human rights, says UN expert

Innovative investment could help solve the world’s water crisis – here’s how

‘Laser-sharp focus’ needed to achieve Global Goals by 2030, UN political forum told

Music is a vital urban resource. How do we plan for it?

These are the most desirable cities for overseas workers

China and UK relations post Brexit as EU addresses Chinese takeovers

New Disability Inclusion Strategy is ‘transformative change we need’, says Guterres

There is no greater sorrow on earth than the loss of one’s native land

It’s ‘time to #EndTB’, says UN on World Tuberculosis Day

European Solidarity Corps: three years on

Europe moulds global defense and security chart given US new inward vision

Search Engine neutrality in Europe in danger: Are 160.000 Google filtering requests good enough?

UN human rights ruling could boost climate change asylum claims

The unpleasant truth of plastic straws

Why your next car is a bike

Coronavirus: Commission lists key steps for effective vaccination strategies and vaccines deployment

Africa is helping the drone industry get off the ground. Here’s how

Geographical Indications – a European treasure worth €75 billion

The Eurogroup offered a cold reception to IMF’s director for Europe

Scotland in United Kingdom: It’s either the end or the beginning of the end

FIRST PERSON: An artist’s ‘obsession’ with New Orleans tradition

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s